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FROM THE
PRESIDENT

Progress has
continued on the development of
a P}1ysician Well-Being &rroup. A
Task Force has been formed to
organize the first session which is
tentatively scheduled for midJune.
Arrangements have been made to
retain the services of a clinical

psychologist, experienced in such
groups, to facilitate the process .
We are quite excited about the
prospect of having such a support
group available on an ongoing
basis at our hospital as a resource
for our Medical Staff.
The Clinical Plan is in rough draft
form and presently under
consideration by the Board
Once
Planning Committee.
finalized, it will be presented to
the Medical Executive Committee
and will be available for review
by the Medical Staff.

The formal MissionNision
Statement from the Medical Staff,
as well as the primary Goals and
Objectives, generated from our
recent weekend retreat are
currently being reviewed and
finalized and will soon be
available for presentation, initially
to the Medical Executive and Past
Presidents Committees.
This
information, which we feel is of
critic:'!! importa11ce for (l•Jr fuwr~.
direction, will be presented
thereafter at a General Medical
Staff meeting.
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Medical Staff Progress Notes

Correspondence
President-elect

for

Effective May 1, 1991, all official
correspondence regarding Joseph
A. Candio, M.D., as Presidentelect of the Medical Staff, should
be forwarded to the Medical
Affairs Office at the L VHC site.
This includes all meeting notices
relating to Dr. Candio in this role.
All clinical information
concerning Dr. Candio's private
practice should continue to be
forwarded to his office -- Candio,
Feldman, Kovacs & Guillard,
1230 S. Cedar Crest Blvd., Suite
201, Allentown, PA 18103.
you have any questions
regarding this issue, please contact
either John W. Hart, Vice
President, at 776-8968, or Rita M.
Mest, Medical Staff Coordinator,
at 778-2244.

If

Physician Information
Services (1/S) Liaison
Position Approved
At its May 7 meet1ng, the Medical
Executive Committee unanimously
supported HEI/TAH--LVHC
continuing its efforts to acquire a
new patient care information
system from PHAMIS.
The
Medical Executive Committee
also unanimously supported
creating a paid, part-time
Physician 1/S Liaison position to
provide physician leadership in
implementing and using the
PHAMIS system. A selection
committee will review all resumes
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for the position, conduct all
interviews, and recommend its top
three choices.
John S. Jaffe,
M.D., President, Medical Staff,
and Samuel R. Huston, hospital
President and CEO, will make the
final selection.
Interested candidates should direct
any questions and/or mail their
resumes for consideration to
Richard Duncan, Chief
Information Officer, 2024 Lehigh
Street, Allentown, P A 18103,
(778-1406), or John W. Hart, Vice
President, Medical Affairs Office,
L VHC site, (776-8968), on or
before Monday, May 27.

National Practitioner Data
Bank
Within two years, the National
Practitioner Data Bank will have
a file on all physicians licensed to
practice medicine in the United
States who have hospital
privileges. As many physicians
are not clear on many of the
regulations governing the Data
Bank, the Pennsylvania Medical
Society recently released a new
booklet which explains how the
Data Bank will operate and its
impact on physicians.
This
booklet very simply explains some
of the most-asked questions
regarding the reporting of actions
to the Data Bank.
Copies of this booklet are
available in the Medical Affairs
Office at both sites. To obtain a
copy, please call either Sally
Roessler at 776-8968 (LVHC
site), or Bess Ehnot at 778-2244
(TAH site).
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Attention Laser Users m
LVHC Site
The Sharplan 1110 Carbon
Dioxide Laser, located at the
LVHC site, has been repaired and
is available for use by all
specialties.
Therefore, when
scheduling procedures with the
operating room at the L VHC site,
it will be assumed that this piece
of equipment will be used unless
another laser 1s specifically
requested.
If you have any questions
regarding this issue, please contact
Joanne Porter, R.N., B.S.N.,
CNOR, Head Nurse, Operating
Room, at 776-8760.

Drug Trial for Insuliu
Dependent Diabetics
The Allentown Hospital--Lehigh
Valley Hospital Center is one of
60 sites in the nation conducting
an oral Clrug trial to help slow the
development of kidney disease in
Type I diabetics. Our goal is to
enroll 15 patients within the next
nine months.
Study candidates must meet the
following criteria:

* insulin dependent diabetes
mellitus for five to 20 years
* normal blood pressure
* 18 to 50 years of age
* non-childbearing (females must
be post-menopausal or surgically
sterile)
* rnicroalburninuria
* free from serious heart, liver,
and renal disease
(Continued on Page 3)
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(Continued from Page 2)
For more information, please
contact either Nelson Kopyt, D.O.,
co-primary investigator, 432-8488,
Robert Doll, Jr., M.D., co-primary
investigator, 820-9557, or Mary
Ann Gergits, R.N., study nurse,
through the page operator at
776-8999, or in the Department of
Medicine at 776-8200.

Foot Care
Education

Patient

Two quality assurance audits were
done over the past year to
determine diabetic patients'
knowledge of daily foot care.
Unfortunately, only 53% of all
patients surveyed indicated that
they were taught how to care for
their feet. Since many patients
seen in the hospital already have
foot problems, the best
preventative measure is for all
health professionals to include
foot care education in primary
health care settings.

3
site, and paper, cardboard, tin, and
glass at TAH site. The added
items at T AH are due to more
stringent requirements by the City
Please note,
of Allentown.
however, that tin and glass need
only be recycled by the cafeteria
at TAH.
Gray collection containers have
been placed throughout both
hospital sites.
The following
items are acceptable for recycling:
all white paper with any color ink,
computer paper, white stationery
and letterheads, white business
forms, white tablet sheets, tab
cards, white machine copies,
white non-window envelopes, and
white folders or report covers.
Your cooperation and input into
the hospital's recycling efforts
will be greatly appreciated.

For more information about these
audits or about foot care patient
education, please contact Bonnie
Kosman, R.N., C.D.E., Diabetes
Nurse Educator, at 776-8775.

Hospital Recycling
Program Expanded
As you may know, the hospital
has been recycling aluminum cans
for several years. Effective April
15, the hospital's recycling
program was expanded to include
paper and cardboard at the LVHC
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cerebrospinal fluid and serum
specimens.
Based on data
generated between October 1990
and January 1991, urine bacterial
antigen tests will not be offered
because of the unacceptably high
number of indeterminate results
that occur with this type of
specimen. These findings are also
consistent with those observed in
other laboratories.
Antigen detection tests should
only be ordered as an adjunct to
culturing for patients who have
other abnormal parameters, e.g.,
elevated WBC, decreased glucose,
and have been partially treated.
Bacterial antigen detection appears
to offer no advantage over Gram
stain and culture in patients who
have not been on antibiotics.
you have any questions
regarding this issue, please contact
either Gale Fritch, MT,
Supervisor, Immunology and
Endocrinology, at 778-2845, or
Diane ,c. Halstead, Ph.D.,
Director, Microbiology/
Virology/Immunology, at
776-8150 or beeper 1193.

If

Ionized Calcium .4nalyses

Bactigens
Effective immediately, latex
agglutination tests (Bactigens) for
Haemophilus influenza type b,
Streptococcus pneumoniae,
Neisseria meningitides groups A,
B, C, W13.), Y, and Group B
Streptococcus agalactiae antigens
will only be performed on

Ionized calcium analyses are
available at both sites on a STAT
24 hour basis. The preferred
specimen is a green top lithium
heparin whole blood tube but
serum can also be used.
you have any questions
regarding this issue, please contact
Gerald E. Clement, Ph.D.,
Director, Toxicology, at 776-8156
or 778-2534.

If
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Scarpelli. Pulmonary Physiology:
Fetus, Newborn Child and
Adolescent. 2d ed. Lea &
Febiger, 1990.

The Health Sciences Library at
the L VHC site recently acquired a
MACINTOSH computer which
has been placed adjacent to the
MEDLIN£ system. One of the
CD programs on the
MACINTOSH is Knowledge
Finder, which contains a subset of
MEDLINE consisting of the 200
core English language journals
representing the medical literature.
Most of the core journals are
available in the libraries. This
may be advantageous if immediate
retrieval of an article is necessary.
Another CD product on the
MACINTOSH is STAT! Ref:
Primary Care Library Series I.
This following books are available
on this CD:
AHES Drug Fonnulary '90
Scientific American Medicine
Current Emergency Diagnosis and
Treatment. 3d ed.
Current Medical Diagnosis and
Treatment. 1990
Current OB/GYN Diagnosis and
Treatment. 6th ed.
Current Pediatric Diagnosis and
Treatment. 1Oth ed.
Current Surgical Diagnosis and
Treatment. 8th ed.
Basic and Clinical lnununology. 6th ed.
Basic and Clinical Pharmacology. 4th ed.
Review of General Psychiatry. 12th ed.
Review of Medical Physiology. 14th ed.
Smith's General Urology. 12th ed.

Some of the most recent book
acquisitions at T AH site include:

Cassel. Geriatric Medicine. 2d
ed. Springer Verlag, 1990.
Shingleton. Postreproductive
Gynecology.
Churc.hill
Livingstone, 1990.
Goodman. Goodman and
Gilman's The Pharmacological
Basis of Therapeutics. 8th ed.
Pergamon, 1990.
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Discharge Summaries
The format for Discharge
Summaries is posted at each
dictating station throughout the
All of th"' following
hJ·o"-:~-areas need to be dictated in order
to meet JCAHO and bylaw
requirements:
1
.;.)p.i.L4l1.

•

...

....

""

.&

* Date of Admission

* Date of Discharge
* Final Diagnosis
* Secondary Diagnosis
* Procedure/Operation

* Consultations

* Reason for Admission
* Diagnostic Data
* Hospital Course

......

* Disposition
* Condition Upon Discharge
* Follow-Up Instructions
Those areas not dictated will be
flagged.
Your attention to this issue will be
greatly appreciated.

Physician
Reminder

Attestation

HCFA requires that attestations be
signed upon or immediately
following a patient's discharge.
Physicians are reminded to stop
by the Medical Record
Department at T AH site or the
Doctors' Lounge at LVHC at
least on a weekly basis in order
to comply with HCFA 's
requirements and to insure
uninterrupted cash flow to the
hospital.
Your cooperation is appreciated.

Free Skin Exams to be
Offered
Free skin examinations will be
provided by physicians from the
Lehigh Valley Dermatology
Society at selected location in the
Lehigh Valley.
A screening will be offered in the
Clinics at TAH site on Saturday,
May 18, from 1 to 4 p.m.
Appointments are recommended
and may be scheduled by calling
the Comprehensive Community
Cancer Center at 778-2582.
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Revised Telephone Hotlist
With last month's newsletter, a
copy of the Telephone Hotlist was
distributed to all physicians and
office managers. The hotlist is a
quick reference of the most
commonly used hospital telephone
Since then, several
numbers.
changes have been made to the
hotlist. A copy of the new hotlist
is being distributed to all
physicians and office managers
with this month's newsletter.
Additional copies of the new
telephone hotlist are available in
the Medical Staff Lounge at both
sites or by calling the POPS
Office at 778-2780.

TAH--LVHC
Round bailers
Deflate Good
Samaritan
On Thursday, April 18, before the
not-so-packed gymnasium of Blue
Mountain High School,
Orwigsburg, the roundballers of
TAH--LVHC managed to hold off
a fme squad from Good Samaritan
Regional Medical Center and
came out on top with a 69-60
victory.
With a superb effort from the
Twin Towers of Tony Furey,
M.D. (24 points), medical
resident; and Randy Stubits (6
points), Director of Logistics,
Materials Management, T AH-L VHC Roundballers were too
much for the "boys" of Good
Samaritan to handle. Additional
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scoring support was received from
Bret Bissey (17 points),
Administrative Assistant; Geoffrey
G. Hallock, M.D. (6 points),
plastic surgeon; Jack Dunleavy (4
points), Assistant Director, Human
Resource Development; Joe
Bubba (4 points), legal counsel;
and Will Mest (4 points),
Supervisor, Mailroom, LVHC
Site. Although he missed the
team bus and arrived with only
three minutes left in the game,
John S. Jaffe, M.D., President,
Medical Staff, rounded out the
scoring with 4 points.
Highly creative defensive moves
were provided by John W. Hart,
Vice President; John Boroski,
Director, Admission Services;
Mike Kaufher, Vice President,
Public Relations; and John A.
Kibelstis, M.D., pulmonologist.
Stay tuned for an announcement
regarding the date for a rematch if
the "boys from Good Sam"
recover from their bruised egos!

CONGRATULATIONS!
Three members of the Medical
Staff recently received faculty
appointments at Hahnemann
University in the Department of
Medicine. David B. Goldner,
M.D., cardiologist, and Harold
Kreithen, M.D., allergist, were
appointed Clinical Assistant
Professors, and D. Lynn Morris,
M.D., cardiologist, was appointed
Associate Professor.
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Thomas E. Young, M.D., gent
internist, was informed by tiL
American Board of Internal
Medicine that he successfully
passed the certifying examination
and is now certified as a
Diplomate in Internal Medicine.
Iris A.
Brossard,
M.D.,
neurologist,
and her husband, William
Mulligan, recently welcomed a
baby daughter on April 17.
Melissa weighed in at 8 lbs. and
She was
was 21 in. long.
welcomed home by her sister,
Amanda.
Drs. John D. and Sara C.
Karabasz, members of the
Department of Dentistry, recently
gave birth to a baby boy on April
17. Benjamin weighed 9 lbs. 1
oz., and was 21 3/4 in. long. He
was welcomed home by his sister,
Kate.
Mark A. Kender, M.D., general
internist, and his wife, Patty,
recently welcomed a baby
daughter on April 21. Abigail
Kelly weighed in at 8 lbs. 2 oz.
and was 21 1/2 in. long. She was
greeted by her two-year old
brother, Christopher.
Rita M. Mest, Medical Staff
Coordinator, was elected Secretary
for the Pennsylvania Association
for Medical Staff Services
(P AMSS) at the annual meeting
held recently in Strasburg, Pa.
(Continued on Page 6)

Medical Staff Progress Notes
(Continued from Page 5)
PAMSS is a state chapter of the
National Association of Medical
Staff Services (NAMSS). This
organization provides support to
the Medical Staff Services
Professional with education
regarding the ever-changing
mandates imposed on Medical
Staff functions by the State and
Federal governments and other
regulatory agencies such as
JCAHO.
Mrs. Mest is also Membership
Chairman of the local
(Southeastern Pennsylvania)
chapter of NAMSS.

Publications, Papers and
Presentations
Herbert

L. Hyman, M.D.,
gastroenterologist and senior
consultant in Gastroenterology,
spoke on "The Irritable Gut" at
the Delaware Valley Hospital in
Langhorne, Pa., on April 16.

Peter

A.

Keblish,

M.D.,

orthopedic surgeon, was invited to
speak in Leipzig, Germany, in
early April at the Cementless Hip
& Knee Replacement: Over 12
Years with AML and LCS
meeting which was organized by
Dr. W. Arnold, Orthopedic Clinic
Director of the Karl Marx
University of Leipzig, in
cooperation with MEDINORMDePuy of Germany.
Dr.
Keblish's talks included "LongTerm Results with the LCS
Unicompartmental Device
(Designs and Results)" and
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"Operative Technique: Varus &
Valgus Knees."
Additionally, Dr. Keblish also
participated in the International
Course on Primary Hip Surgery
held in Turin, Italy. He spoke on
"AML in Primary THA" as part
of an Uncemented Prostheses
symposium. He also joined in a
"Stem Problems" Round Table
that covered the following topics:
materials, cemented/cementless,
press-fit/bone ingrowth, fixation,
stem types, head size and
material, collar/no collar, and
local complications. Dr. Keblish
conducted an AML device
workshop as well.
Dr. Keblish then attended Les
Journees High-Tech, a one and a
half day meeting held in Avignon,
France.
His presentations
included "Problems with Long
Straight Stem in Revision THA:
The Case for the Solution System"
and "AML TriSpike Acetabular
Component: Technique Points
and Clinical Experience." He
served as moderator for the
scientific program on Hip
Revision/Cup Systems.
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TAH--LVHC Regional
Symposium Series

Contemporary Diagnosis and
Management of Hypertension

will be held on Saturday, June 8,
from 8 a.m. to 12:30 p.m., in the
Auditorium of the LVHC site.
Family practitioners, general
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practitioners, general intern1
nurses, dietitians, and any oth
health care professionals interesteo
in hypertension will benefit from
the program.
At the completion of the
symposium, participants will be
able to state the diagnostic and
therapeutic approaches to
hypertension in the 90s.
For more information about the
conference, please contact Human
Resource Development at
776-8322.

Pediatric Conference Schedule

Ever Changing Schedule for
Immunizations will be presented

by Sarah Long, M.D., Chief,
Section of Infectious Disease, St.
Christopher's Hospital fo·
Children, on May 31.

Toxic Shock Disease will be
presented by Margaret C. Fisher,
M.D., Section of Infectious
Disease, St. Christopher's Hospital
for Children, on June 14.
Conferences are held Fridays at
noon in T AH Auditorium. For
more information, contact Beverly
Humphrey in the Department of
Pediatrics at 778-2540.
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HealthCounts News
Having a healthy mind and body
is one of nearly everyone' top
concerns.
HealthCounts, the
employee and community
wellness program of The
Allen town Hospital-- Lehigh
Valley Hospital Center, has
designed a series of programs and
public lectures concerning health
promotion and disease prevention.
In support of the nation's Healthy
People 2000 goals and the mission
of our hospital to improve the
health status of our community,
information on a wide range of
topics will be presented by
physicians and other health
professionals affiliated with the
hospital.
Programs for May include:

The Cornea--Window of the Eye
will be presented on Monday,
May 20, from 7 to 9 p.m., in the
Auditorium ofTAH site, by Harry
W. Buchanan IV, M.D.,
ophthalmologist. Learn how eye
trauma and contact lens-related
cornea ulcers may lead to the
need for a cornea transplant. The
transplant procedure will also be
discussed.
The following two lectures will
focus on issues and choices
pertaining to tough decisions at
critical times that patients and
families of the terminally ill must
face. To receive the best possible
healthcare, understanding and
communication between the
medical community, the patient,
and their family is vital.
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Both lectures will be held from 7
to 9 p.m. in the Auditorium at the
LVHC site. Joseph E. Vincent,
M.D., pulmonologist and critical
care director ofTAH--LVHC, will
be the speaker.

What Choices Do You Have?
will be presented on Wednesday,
May 22. What risks are you
willing to take for what benefit?
Would you want to be resuscitated
from cardiac arrest if you had a
terminal illness? Would you want
to be fed artificially if you were
in a permanent coma?
This
lecture will focus on
withholding/withdrawing, "do not
resuscitate," and brain death.
Who Chooses When You Can't?
will be presented on Wednesday,
May 29. Do you know what your
wishes are medically and, if so,
does anyone else? Find out about
living wills, durable powers of
attorney, and organ donation.
For more information one these
lectures, contact HealthCounts at
821-2150.
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QUOTEO£ THE</··
MONTH>

.~~···i~i~i~~~~;
PHYSICIAN PRACTICE
OPPORTUNITIES
*Monday and Wednesday morning slots
are currently available for the Brown Bag
suite at Kutztown Professional Center.
* Kutztown Professional Center is
planning a 5,500 square feet addition for
Fall, 1991. Office suites available will
include medical, dental, legal, and
professional.

For more information on these
practice opportunities, contact
John W. Hart, Vice President, at
776-8968.

* Specialty practice time-share space
available in a comprehensive health care
facility. Riverside Professional Center,
4019 Wynnewood Drive, Laurys Station.
Half- or full-day slots immediately
available.
* Office space available at 1111 N. 19th
Street, Allentown. 1,080 square feet.
* Temporary office space available on
first floor of Fairgrounds Medical Center,
400 N. 17th Street, Allentown. 380 square
feet for one- or two-year lease. Private
entrance.

For more information, contact Joe
Pilla, POPS Representative, at
776-8225.

Medical Staff Progress Notes

WHO'S NEW
The

Who's

New

section

of

Medical Staff Progress Notes

contains an update of new
appointments, address changes,
newly approved privileges, etc.
Please remember that each
department or unit is responsible
for updating its directory,
rolodexes, and approved privilege
rosters.

Medical Staff
Change of Status

Internal Medicine Physicians with
Pediatric Privileges

Mark A. Staffaroni, MD
Department of Surgery
Division of Ophthalmology
From Active to Courtesy

Family Practice Physicians with
Privileges to Attend Deliveries
and C-Sections

Family Practice Physicians with
Pediatric Privileges
Judith N. Barrett, MD
Neal J. Berkowitz, MD
Charles T. Bonos ill, MD
Sam Bub, MD
Ronald J. Buckley, MD
Michael V. Buenaflor, MD
Todd A. Cassel, MD
James R. Clifford, MD
Theodore W. Eastland, MD
Bruce A. Ellsweig, MD
Steven Farbowitz, MD
Michael S. Hartner, MD
Alan W. Johnson, MD
John R. Lapp, MD

Solo Practice

Fred Laufer, MD
Henry E. Lehrich, MD
Jack A. Lenhart, MD
Paul J. Lynott, MD
Dennis M. McGarry, DO
Lisa H. Medina, MD
Peter H. Neumann, MD
Harvey B. Passman, DO
Richard C. Pearce, MD
George L. Provost, MD
Fred H. Roland, MD
Wendy J. Rush Spinosa, MD
Kenneth G. Ryder, Jr., MD
Howard A. Silverman, MD
Daniel M. Spatz, Jr., MD
David W. Whitson, MD
Brian D. Wilson, MD
John F. Wolf, MD

Thomas 0. Burkholder, MD
Department of Surgery
Division of Ophthalmology
From Active to Courtesy

Additional Privileges
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Mark A. Kender, MD

Neal J. Berkowitz, MD
Todd A. Cassel, MD
Bruce A. Ellsweig, MD
Steven Farbowitz, MD
Wendy J. Rush Spinosa, MD
Kenneth G. Ryder, Jr., MD
John F. Wolf, MD
Internal Medicine Physicians with
Privileges to Attend Deliveries
and C-Sections
Mark A. Kender, MD

(no longer associated with Ronald
DiLeo, DDS)

r

Dieter W. Leipert, DDS
7540 Windsor Drive
Suite 100
Allentown, PA 18195
(215) 481-9928

Allied Health Professionals
Appointments
Carl J. Cuvo, PA-C
Physician Extender
Physician Assistant
Lehigh Valley Orthopedics

'

Patti Ann Hutchinson, RN
Physician Extender
Professional Category - RN
Concepcion T. Yen, MD

Resignations
Mark W. Boyer, RN
Physician Extender
Professional Category - RN
John J. Cassel, MD

Change of Supervising Physician
John M. Holley, RN
Physician Extender
Professional Category - RN
From Lehigh Valley Orthopedics
to
George A. Arangio, MD, PC

DRUG INFORMATION BULLETIN
THE ALLENTOWN HOSPITAL--LEHIGH VALLEY HOSPITAL CENTE1
PHARMACY DEPARTMENT

April, 1991

Editors:

Chen -Pei L. Goldman, R.Ph., M.S. & Richard M. Attilio, R.Ph., M.S.

Adverse Drug Reactions : Reactions to Reporting
Through a retrospective revievv of the spontaneous reporting of Adverse Drug Reactions at
our institution, the Pharmacy Department identified a deficiency in our current reporting
system. For this reason, vve surveyed nursing, pharmacy, the medical and surgical house
staffs, and attending physicians for their perceptions of ADR reporting. 164 surveys vvere
completed and returned.

What is a Reportable ADR Anyway?

Our first discovery vvas an inconsistency in the perceived definition of a reportab1e
Adverse Drug Reaction. This lack of a consistent definition may be a source of confusion in
regard to vvhether or not a reaction should be reported.

Better Patient Care or More Paper Work?

Our second discovery vvas that 80% of the people surveyed believe that there is a purpose
for ADR reporting. Of this 80%, about one half report for a reason ultimately related to
oatient care. Unfortunately, the other half of the hospital personnel report ADR's because
hey are manda~ to do so. Until vve make patient care our primary purpose for
reporting, this motivational factor vviU also contribute to the under reporting of adverse
drug reactions.

How Do We report ADRs?

Our third inquiry vvas into the methods currently being utilized for ADR reporting. We
discovered that more than 50% are reporting through the PERTS form alone, 40% report
through both the PERTS and HIS cotnputer system, and approximately 10% use another
method of reporting. Amon& the other methods mentioned vvas the use of an ADR report
form, vvhich our hospital does not yet have. Therefore, a lack of avvareness of our current
ADR system exists.

P.E.R. T.S. form Facts:

We assessed the usefulness and appropriateness of the PERTS form in the area of ADR
reporting. We discovered that the PERTS form presents a liability fear, a negativity
associated vvith error, a long turnaround time betvveen ADR occurrence and the initiation
of fotlovv-up, and a format not specific to ADR's. Therefore, it does not extract the relevant
information needed for effective fotlovv up.
91% of the surveyed personnel indicated that the implementation of a specific ADR form is

5trongly recommended. The survey al5o indica~ the need for a common adverse drug
reaction definition on the ADR form for those vvho are unsure vvhen to report, and the
provision of inservices to ensure complete knovvledge of the adverse drug reaction
reporting system by all hospital personneL Currently, development of an Adverse Reaction
Report form is being explored in conjunction vvith a number of other departments. Stay
tuned for more on this important clinical issue. Mary Bradley, R.Ph., Resident
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Metamucil.' Metamucil! How mucn snouta

1

""'rue

rur-:

Metamuci1, a bulk-producing laxative, is commercially available as a regular or sugar-free
formulation vvith various flavors in a bulk povvder or a pre-measured packet form. The
~commended normal adult dose is 3.4 Gm of psyllium hydrophyllic mucilloid, the acth•e
mgredient of metamuciL The volume of povvder containing that dose i.e. 1 tablespoon or 1
teaspoon, hovvever, is dependent on the formulation or the flavor. Pharmacy presently
only stocks the metamucil packets. Regardless the types of formulation or flavor, e\ 1
packet contains J.4 Gm of active ingredient. Therefore, in order to alleviate confusion and
'\vaste, Physicians are requested to vvrite for metamucil as packets rather than as
teaspoons or tablespoons.
Mary F. Johnstone, R.Ph.

Parenteral Antibiotic Usage Facts:
The cost of parenteral antibiotics in 1990 vvas approximate 1.75 million dollars at
TAH--LVHC. These figures represented 30% of the total drug costs. The top five most
costly and most frequenty used parenteral antibiotics are listed belovv:

LVHC
Rank

Cost

TAH

Use <doses>

Cost

Use<doses>

1

Ceftazidi.E

S266,00

Cefazolin

56,069

Ceftazidi.E S70, 796

Cefazolin

14,403

2

Cefazolin

S207,383

Vanco11ycin

23,645

Cefoxitin

S62,131

Allpicill in

10,351

3

Vanco11ycin

S136,163

Gentallicin

17.422

Cefazolin

S50,430

Genta11icin

8,532

4

Piperacillin

s 97,378

Ceftazidi11e 15.231

Ceftriaxone S45,745

Cefoxitin

5,832

5

Ceftriaxone

s 91.895

Allpicill in

Vanco11ycin

Ceftazidi11e

5.190

9.972

S43,724

As shovvn in the table above, Ceftazidime vvas a very costly acent. It ranked as No.1 in c.. G
and captured approxtniate S337,()(X) of the pharmacy drug budget. It vvas also a commonly
prescribed drug by the medical staff, ranked No.4 and No.5 of most frequently used agents
at L VHC and T AH. respectively.
The fact is this phenomenon could have been avoided if the recommended usage guidelines
'\Vere foUovved by all ceftazidime pt"85Cf"'ibers. The guidelines state that ceftazidime is
indicated in suspected or docwnented infections caused by organisms suseeptible to
Ceftazidime but resistc:zn.t to other less broad spect.ru.n, less costly antibiotics or if the
use of other ant.iblot.ics Is contralndlcat.d.
The frequent use of C.ftazid.Un• can ca~ the em•rgence of ceftazidime-resistant organism
strains. At LVHC, the antl-psudomonal activity of ceft.azidime is only 76% against the
isolates obtained fi'Om the critical care units vs. 92%. against the isolates obtained from the
med-surg units. Physicians are uraecf to comply vvith the ceftazidime usage guidelines to
prevent the further emergence of resistant strains. C.P. Go'ldtnan, R.Ph., M.S.

Cholestyramine Information Sheet-- Preventing Drug Interactions
Cholestyrsunine Resin (QuestranR) is a bUe acid sequesterina aaent used in the management
of hyperlipidetn.ia. It is capable of reducina the absorption of numerous drur by bindina to
the drug in the Gl tract or by interfering vvlth enterohepatic circulation. For this reason
the Pharmacy Department vvlU send a cholestyramine drug interaction sheet to the
patient's nursint unit to notify nurslnc personnel and the physician vvhen an interacting
combination has been prescribed. Recommendations for alternative medication schedutol!s
are listed for interactions of moderate to major significance. Richard Townsend, R.P.
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THE ALLENTOWN HOSPITAL--LEHIGH VALLEY HOSPITAL CENTER
DRUG INFORMATION SHEET
Drug Interactions with Cholestyramine (Questran)
~~~--~----~----~has

(Patient name/room #)

been prescribed Cholestyramine (Questran).

Please consider the following drug interactions when scheduling medications. As a general rule,
decrease in effect of the object drug.

cholestyraai~e

will cause a

Drug
'Ac"e't am inop hen

Mechanism

Reconendation
Monitor for lack of acetaminophen efficacy. Schedule acetam1nophen at least 1 hour
before or several hours after cholestyramine to minimize interaction.·

Antibiotics:
Cephalexin
Clindamycin
Metronidazole
Peni:illin
Tetracycllne
Trimethoprim

A

If concom1tant therapy is required, give antibiotic 1 hour before or 4·6 hours after
cholestyramine.·

Corticosteroids
cortisone Acetate
Dexamethasone
Prednisone and others

A

Monitor for decreased response to corticosteroid. Schedule doses as far apart as
possible:

Digitalis Glycosides

A, B

Monitor for decreased response to digitalis glycosides. Schedule digitalis product
at least 1-2 hours prior to cholestyraaine to ainitize interaction.·

Folic Acid

A

If conco1itant therapy is required schedule doses as far apart as possible.·

Methotrexate
(IV, PO)

A, B

Monitor for decreased response to Methotrexate. Schedule doses as
far apart as possible.·

Phenobarbital

A

Monitor for decreased response to phenobarbital. Schedule doses as far apart as
possible.t
'

Thiazide Diuretics
Hydrochlorothiazide
and others.

A

Monitor for decreased response to thiazide diuretic. Schedule thiazide at least 2
hours prior to cholestyraaine.·

Thyroid Hormones
Levothyroxine
Liothyronine
Thyroid

A

Monitor for decreased response to thyroid horaone. Schedule doses at least 4-5 hours
apart:

Warfarin (IV, PO)

A, B

Avoid concotitant use if possible. Monitor for altered anticoagulant response
when therapy is initiated, discontinued or changed in dosage. Schedule warfarin at
least 6 hours after cholestyratine to 1ini1ize interaction.·

A

EXAMPLE: If both the antibiotic and cholestyramine are to be administered ault1ple
t1mes daily (i.e. TID, QID, etc) simply schedule the antibiotic 1 hour before the
cholestyramine. This should allow for a 11nitu1 of 3 hours between the antibiot1c and
the previous cholestyramine dose, even if scheduled q4h.

NOTE: only drug interactions of aoderate to 1ajor significance are listed. Cholestyratine has the potential to interact with aany
------other medications. consult the Clinical Pbaraaey Service (LVRC·8884, TAH-2797} if further infortation is des1red.
ADecreased or delayed absorption of object drug.
Blmpairaent of enterohepatic circulation.
' If separating dosage schedule tiae does not achieve the desired response, dosage adjusttent 1ay be necessary.
This information is to be placed in the patient•s chart with the chronological list of medications for use by Nursing &Medical
Personnel. It 11 not a per1anent part of the 1ed1cal record and should be reaoved when the patient is discharged. Par
•••i•t~n~g with rin~P sebednlina. contact the Phartacy Departtent.

P & T HIGHLIGHTS

The Allentown Hospital - Lehigh Valley Hospital Center

PHARMACY DEPARTMENT
James Giardina, R.Ph., M.S. - Editor

Actions Taken at the April 11, 1991 P&T Committee Meeting
IMFOIIUTION INI'OIIU.TION INI'OIItATION
The Committee reviewed and approved patient education medication information sheets
on Metronidazole, Narcotic Analgesics, Phenytoin, Beta Blockers, Lovastatin and
General Reminders for Patients on Psychiatric Medicines.
I

I

Fonml.ary Addi tiona/Bejectiona

The Committee approved the addition of Caffeine and Sodiu. Benzoate Injection to the
formulary. This agent was requested for the unlabeled use of increasing seizure
duration during Electroconvulsive Therapy (ECT). The mechanism of action may be
related to an inhibiting effect of caffeine on adenosine receptors, receptors which
have been associated with anticonvulsant activity. The doses employed in ECT range
from 250-lOOOmg given IV push over 30 seconds.
The Committee discussed the addition of filgrastt. (Neupogea, Amgen) most commonly
known as G-GSF (Granulocyte- Colony Stimulating Factor). Filgrastim specifically
stimulates neutrophil granulocyte proliferation, migration and maturation in
neutropenic patients. It is indicated to decrease the incidence of infection in
patients with non-myeloid malignancies receiving myelosuppressive anti-cancer agents
associated with a significant incidence of severe neutropenia with fever. The
recommended starting dose is 5mcg/Kg/day given subcutaneously or intravenously as a
single injection. Treatment is started no sooner than 24 hours after cytotoxic
chemotherapy. Therapy should conti~ue for up to two weeks or until the absolute
neutrophil count exceeds 10,0000/mm • The most common adverse reactions are bone
pain (prophylaxed with acetaminophen), elevated LDH, alkaline phosphate and uric
acid levels. Specific usage criteria are being sought from Hematology/Medical
Oncology prior to a formulary decision.
ODdaasetrao (Zofraa, Glaxo) is a 5-hydroxytryptamine3 receptor antagonist which
blocks vagal afferent nerve stimulation of the vomiting center. It is indicated for
the prevention of nausea and vomiting associated with emetogenic cancer
chemotherapy. Ondansetron is metabolized by the cytochrome P-450 system and, as
such, inducers or inhibitors of this system may alter its clearance or half life.
Common side effects include headache, diarrhea and constipation. Unlike
metoclopramide end prochlcrper=ine, there ere no reports of extrapyramidal side
effects or tardive dyskinesias. The recommended IV dose is O.l5mg/Kg given over 15
minutes beginning 30 minutes prior to chemotherapy; subsequent doses should be given
at 4 & 8 hours after the first dose. Ondansetron costs $170.00/40mg compared to
$56.00 for a comparable metoclopramide regt.en.
~

for Reaal Perf•iaa

The committee approved the use of low dose (i 3mcg/Kg/min) fixed rates continuous
infusions of dopamine in patients on unmonitored units to maintain renal perfusion.
This therapy had been limited to areas caring for dialysis patients; however, it
will be expanded to several other patient types who can benefit from this therapy.
Dopamine should be ordred as Dopamine for Renal Perfusion. It will be dispensed
only as 200mg in 250cc fluid.
AdditiODII to lfurai.JW IV Ouideli.DM

CycloeporiDe - okay to give by infusion over 2-6 hours in all areas
AzathiopriDe - IV push over 5 minutes or infuse over 30-60 minutes in all areas.
lrythropoetiD- IV push in all areas (SQ adm. doses may have a longer duration).

